¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Calcium Channel Blocking Agents"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • calcium phosphate stone
    ÀλêÄ®½·µ¹
  • calcium pump
    Ä®½·ÆßÇÁ
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • collateral channel
    °çÅë·Î
  • collector channel
    Áý°á°ü, Áý°á·Î
  • cation channel
    ¾çÀÌ¿ÂÅë·Î
  • channel
    Åë·Î
  • channel block
    Åë·ÎÂ÷´Ü
  • fast channel
    ±Þ¼ÓÅë·Î
  • gated channel
    °ü¹®Åë·Î
  • ion channel disorder
    ÀÌ¿ÂÅë·ÎÁúȯ
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • voltage gated channel
    Àü¾ÐÀÛµ¿Åë·Î
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • channel block
    Åë·ÎÂ÷´Ü
  • channel
    Åë·Î
  • cation channel
    ¾çÀÌ¿ÂÅë·Î
  • collateral channel
    °çÅë·Î
  • collector channel
    Áý°á°ü, Áý°á·Î
  • fast channel
    ±Þ¼ÓÅë·Î
  • gated channel
    °ü¹®Åë·Î
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • transmembrane channel
    ¸·Åë·Î
  • voltage gated channel
    Àü¾ÐÀÛµ¿Åë·Î
  • parallel channel sign
    ÆòÇà°ü¡ÈÄ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ganglionic blocking agent
    ½Å°æÀýÂ÷´ÜÁ¦.
  • genetic blocking
    À¯ÀüÀû Â÷´Ü(ë¶îîîÜó´Ó¨).
  • genetic blocking
    À¯ÀüÀû Â÷´Ü.
  • receptor blocking agent
    ¼ö¿ëüÂ÷´Ü<ºÀ¼â>Á¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • spermicidal agents
    »ìÁ¤Á¦(߯ïñð¥).
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°Â÷´ÜÁ¦.
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°(¼º) ºÀ¼â<Â÷´Ü>¾à.
  • alpha blocking
    ¾ËÆÄÂ÷´Ü
  • antibody, blocking
    Â÷´ÜÇ×ü
  • autonomic blocking agent
    ÀÚÀ²½Å°æÂ÷´Ü<ºÀ¼â>Á¦(í»ëÏãêÌèó´Ó¨<Üæáð>ð¥).
  • blocker/blocking agent
    Â÷´ÜÁ¦
  • blocking
    ¸·Èû, ´ÜÀý, Â÷´Ü.
  • blocking agent
    Â÷´ÜÁ¦(ó´Ó¨ð¥).
  • blocking antibody
    Â÷´ÜÇ×ü(ó´Ó¨ù÷ô÷)
  • blocking antibody =blocker
    Â÷´ÜÇ×ü(¡­ù÷ô÷).
  • blocking of thought
    »ç°íÀÇ ¸·Èû
  • blocking test
    Â÷´Ü½ÃÇè(ó´Ó¨ãËúÐ).
  • cholinergic blocking agent
    Äݸ°¼ºÂ÷´ÜÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • calcium phosphate gel
    Àλê(×òß«)Ä®½· Á©
  • calcium pump
    Ä®½· ÆßÇÁ
  • filtrable calcium
    °¡¿©°ú(ʦÕëΦ) Ä®½·
  • free calcium
    À¯¸®(ë´×î) Ä®½·
  • unionized calcium
    ºñ(Þª)ÀÌ¿ÂÈ­ Ä®½·
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NDHPCCB non-dihydropyridine calcium channel blocker
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
VOCC voltage-operated calcium channel
OHA Oral Hypoglycemic Agents
BA Bachelor of Arts; backache; bacterial agglutination; basilar artery; basion; benzyladenine; best amp...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VOCC Voltage-operated calcium channel
VSCC Voltage Sensitive Calcium Channel
VDCC Voltage dependent calcium channel
VGCC voltage gated calcium channel
VOC voltage operated calcium channel
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blocking effect
    Â÷´Ü È¿°ú
  • blocking of thought
    »ç°íÀúÇØ
    Á¤½ÅºÐ¿­Áõ¿¡¼­ º¼ ¼ö ÀÖ´Â °ÍÀ¸·Î¼­ ȯÀÚÀÇ È£¼Ò´ë·Î »ç°íÀÇ ±æÀÌ ¸·Çô¼­ ÀÚ½ÅÀ» Ç¥ÇöÇÏ´Â °ÍÀÌ ¾î·Á¿î Á¤½Å »óÅÂ.
  • cholinergic blocking agent
    Ç×Äݸ°¾à, Äݸ°¼º Â÷´ÜÁ¦
  • depolarizing neuromuscular blocking drug
    Å»ºÐ±Ø¼º ½Å°æ±Ù ºÀ¼â ¾à¹°
  • nerve blocking
    ½Å°æ Â÷´Ü, ½Å°æ Â÷´Ü¹ý
  • neuromuscular blocking agent
    ½Å°æ±Ù Â÷´ÜÁ¦, ½Å°æ±Ù Â÷´Ü ¾à
  • receptor blocking agent
    ¼ö¿ëü Â÷´ÜÁ¦
  • sympathetic blocking agent
    ±³°¨½Å°æ ºÀ¼âÁ¦, ±³°¨½Å°æ Â÷´ÜÁ¦
  • calcium
    Ä®½·
    »ýü Áß¿¡¼­ °¡Àå ´Ù·®À¸·Î ÇÔÀ¯µÈ ¹«±â ¹°Áú. 99% ÀÌ»óÀÌ »À³ª Ä¡¾Æ µî °æÁ¶Á÷¿¡ Á¸ÀçÇÏ¸ç °ñ°ÝÀÇ À¯Áö ¹× Ä®½·ÀÇ ÀúÀå°í·Î¼­ ÀÛ¿ë. °ÅÀÇ ¸ðµç À¯±â Á¶Á÷ ³»¿¡ µé¾î ÀÖ´Â Áß¿ä ¿ø¼Ò. Ç÷¾× ÀÀ°íÀÇ ¿©·¯ ´Ü°è¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí Àֱ⠶§¹®¿¡ ÀÀ°í ÀÎÀÚ ¥³¶ó°í ºÒ·Á ¿Ô´Ù.
  • calcium balance
    Ä®½· ÆòÇü
    ü³»ÀÇ Ä®½· ³óµµ°¡ ¾ÈÁ¤µÇ¾î ÀÖ´Â »óÅÂ.
  • calcium deposit
    ¼®È¸ Ä§Âø
    Ä¡°ú¿¡¼­ Ä¡¾Æ Ç¥¸é¿¡ Á¡ÂøµÇ¾î ÀÖ´Â °æ¼º ¶Ç´Â ¿¬¼ºÀÇ ¹°Áú.
  • calcium gluconate
    ±Û·çÄÜ »ê Ä®½·
    ±Û·çÄÜ »êÀÇ Ä®½·¿°. ¹«Ãë ¹«¹ÌÀÇ ¹é»ö °áÁ¤¼º °ú¸³ ¶Ç´Â ºÐ¸». Ä®½· º¸±Þ¿¡ Á¤Á¦ ¶Ç´Â ¾×ÀÌ »ç¿ëµÈ´Ù. ºÒÈ­¹°À̳ª ¼ö»ê Áßµ¶¿¡ ´ëÇÑ °æ±¸ ÇØµ¶Á¦ÀÌ´Ù.
  • calcium gout
    Ä®½· Åëdz
  • calcium hydroxide
    ¼ö»êÈ­ Ä®½·
    ¹é»ö ºÐ¸»·Î Á¸ÀçÇÏ´Â ¿°. ±¹¼ÒÀûÀÎ ¼ö·ÅÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium hypophosphate
    Ä®½· ¾ÆÀÎ»ê ¿°
    ÆÇÅäÅÙ »êÀÇ ¿ì¼±¼º À̼ºÃ¼ÀÇ Ä®½· ¿°, B º¹ÇÕü ºñŸ¹Î. ¹é»öÀÇ ºÐ¸». ´Ù¸¥ ºñŸ¹Î B¿Í °áÇÕÇÏ¿© ¿µ¾ç °ø±Þ¿øÀ¸·Î »ç¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
blocking 1. Obstructing; arresting of passage, conduction, or transmission.
2. In psychoanalysis, a sudden break in free association occurring when a painful subject or repressed complex is touched.
3. Sudden cessation of thoughts and speech, which may indicate the presence of a severe thought disorder or a psychosis.
(05 Mar 2000)
blocking activity The repression or elimination of electrical activity in the brain by the arrival of a sensory stimulus.
(05 Mar 2000)
blocking agent A class of drugs that inhibit (block) a biologic activity or process, such as axonal conduction or transmission, or ions across a cell membrane; frequently called "blockers."
(05 Mar 2000)
blocking antibody An antibody used in a reaction to prevent some other reaction taking place, for example one antibody competing with another for a cell surface receptor.
See: desensitisation.
(18 Nov 1997)
ganglionic blocking agent An agent that impairs the passage of impulses in autonomic ganglia.
(05 Mar 2000)
Rh blocking test A test for nonagglutinating Rh antibodies: an Rh agglutination test is first carried out; if the test for Rh agglutinins is negative, then 1 drop of anti-Rho agglutinating serum of moderate titre is mixed with the patient's serum containing Rh-positive test cells; if after incubating for from 1 to 2 hr at 37°C no agglutination occurs, Rho-blocking antibodies are assumed to be present in the patient's serum.
(05 Mar 2000)
neuromuscular blocking agent A group of drugs that prevent motor nerve endings from exciting skeletal muscle. They act either by competing for the neurotransmitter, acetylcholine, (like D-tubocurarine, mivacurium and pancuronium), or by first stimulating the postjunctional muscle membrane and subsequently desensitizing the muscle endplates to the acetylcholine (like succinylcholine or decamethonium); used in surgery to produce paralysis and facilitate manipulation of muscles.
(05 Mar 2000)
nondepolarising neuromuscular blocking agent A compound that paralyzes skeletal muscle primarily by inhibiting transmission of nerve impulses at the neuromuscular junction rather than by affecting the membrane potention of motor endplate or muscle fibres.
(05 Mar 2000)
gated ion channel <physiology> Transmembrane proteins of excitable cells, that allow a flux of ions to pass only under defined circumstances. Channels may be either voltage gated, such as the sodium channel of neurons or ligand gated such as the acetylcholine receptor of cholinergic synapses. Channels tend to be relatively ion specific and allow fluxes of typically 1000 ions to pass in around 1ms, they are thus much faster at moving ions across a membrane than transport ATPases.
(05 May 1997)
voltage-gated channel A class of ion channel's that open and close in response to change in the electrical potential across the plasma membrane of the cell; voltage-gated Na+ c.'s are important for conducting action potential along nerve cell processes.
(05 Mar 2000)
voltage gated ion channel <physiology> A transmembrane ion channel whose permeability to ions is extremely sensitive to the transmembrane potential difference. These channels are essential for neuronal signal transmission and for intracellular signal transduction.
See: sodium channel.
(18 Nov 1997)
channel A furrow, gutter, or groovelike passageway.
See: canal.
Origin: L. Canalis
(05 Mar 2000)
channel forming ionophore <chemistry> An ionophore that makes an amphipathic pore with hydrophobic exterior and hydrophilic interior. most known types are cation selective.
(18 Nov 1997)
channel gating <physiology> Small currents in the membrane just prior to the increase in ionic permeability, due to the movement of charged particles within the membrane.
So called because they open the gates for current flow through ion channels.
(20 Mar 1998)
channel islands A group of four british islands and several islets in the english channel off the coast of france. They are known to have been occupied prehistorically. They were a part of normandy in 933 but were united to the british crown at the time of the norman conquest in 1066. Guernsey and jersey originated noted breeds of cattle.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • channel
    ÇöÃø°è·ùÆÇ(µÀ´ëÀÇ ¹öÆÀÁÙÀ» ¸É)
  • channel
    °­¹Ù´Ú;ÇÏ»ó;À¯»ó;¼ö·Î;°¡Ç×¼ö·Î;¿îÇÏ;ÇØÇù;(º¸µµ,¹«¿ª µîÀÇ)°æ·Î;·çÆ®;°èÅë;(Á¤½Ä)Àü´Þ ·çÆ®;(¿Õº¹ µîÀÇ)°æ·Î;(¶óµð¿À.ÅÚ·¹ºñÀü µîÀÇ)ä³Î;(ÇÒ´çµÈ)Á֯ļö´ë;(»ç»ó.Çൿ µîÀÇ)¹æÇâ;¹æÄ§;(Ȱµ¿ÀÇ)ºÐ¾ß;(µµ·ÎÀÇ)µµ¶û;Ãø±¸;¾Ï°Å;¼Ò°ü;µµ°ü;(¹®Áö¹æ µîÀÇ Àå½ÄȨ,(ÀϹÝÀûÀ¸·Î) °¡
  • channel iron (bar)
    Ȩ¼è(UÀÚ ¸ð¾çÀÇ ¼â.¸ø) a
  • channel lease
    ä³Î¸®½º(À¯¼± TVÀÇ ºó ä³ÎÀÇ ´ë¿©(Â÷¿ë))
  • channel separation
    ä³ÎºÐ¸®
  • channel(l)ed
    ȨÀÌ ÀÖ´Â
  • cross-channel
    ÇØÇùȾ´ÜÀÇ;ÇØÇùÀÇ ¸ÂÀº Æí ÂÊÀÇ(ƯÈ÷ ¿µ±¹ ÇØÇùÀÇ)
  • idiot channel
    ¹Î°£ ÅÚ·¹ºñÁ¯ ¹æ¼Û
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á